The Cigna Group
CI: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|<B | LOCK|rjk!n | LOCK|Xz$t%@G |
Cigna Earnings: New Headwinds to PBM Profits Suggest Earnings Growth Pressures May Last Through 2027
Cigna reported third-quarter results, including 10% revenue and 4% adjusted EPS growth. Management also reiterated its 2025 outlook, including at least $29.60 for EPS, and gave an initial view of "growth" for 2026. Cigna also introduced a rebate-free pricing plan for its pharmacy benefit manager.
